#012 Dr. Ronald Krauss on LDL Cholesterol, Particle Size, Heart Disease & Atherogenic Dyslipidemia

Summary

Dr. Ronald Krauss, who developed the assay for measuring LDL particle size and concentration, explains why standard LDL cholesterol numbers miss the full picture. He and Rhonda Patrick discuss the spectrum from small dense LDL to large buoyant particles, how saturated fat versus refined carbohydrates shift that distribution, and what this means for heart disease risk assessment and statin therapy.

Key Points

• Standard LDL-C measurements miss the distinction between small dense LDL (atherogenic) and large buoyant LDL (relatively benign).
• LDL particle number (LDL-P) is a better predictor of cardiovascular risk than total LDL cholesterol concentration.
• Replacing saturated fat with refined carbohydrates shifts the LDL distribution toward more small dense particles, increasing heart disease risk.
• Dietary saturated fat tends to raise large buoyant LDL, which is less strongly associated with atherosclerosis than small dense particles.
• Insulin resistance and metabolic syndrome are primary drivers of the atherogenic dyslipidemia pattern (high triglycerides, low HDL, small dense LDL).
• Advanced lipid testing (NMR or ion mobility) that measures particle size and number provides a much clearer cardiovascular risk picture than standard panels.

Key Moments

Related Interventions

In Playlists